Recent Headlines
Within Biotechnology

AnaSpec’s Published References Passes 600

The number of published papers that cite AnaSpec’s products has passed 600. - May 04, 2008 - AnaSpec, EGT Group

Baxa Announces Colorado BioScience Association Sponsorship

Baxa Corporation recognizes the work of the Colorado Bioscience Association (CBSA) on behalf of the Colorado medical device industry through a corporate sponsorship for 2008. Through the years, Baxa has provided support for CBSA events and activities without a formal sponsorship grant. The company’s investment underlines its support of CBSA initiatives for industry growth, networking and professional education. - May 03, 2008 - Baxa Corporation

AnaSpec Presents Fluorimetric TACE Detection Poster at SBS Conference

AnaSpec presented its latest findings in regards to the detection of TACE activity using FRET technology. - May 03, 2008 - AnaSpec, EGT Group

Baxa Launches Microsite Featuring the MedBoard™ Medication Tracking System

Baxa announces the launch of a microsite dedicated to its MedBoard Medication Tracking System featuring enhanced product information and interactive demonstration tools. Customers can use the site’s interactive tools to explore MedBoard features and benefits, as well as download documents covering frequently asked questions and key product attributes. - May 02, 2008 - Baxa Corporation

Colorado Rep. Bernie Buescher Keynotes the CBSA Annual All-Member Meeting

Representative Bernie Buescher (D-Grand Junction), Chairman of the Colorado General Assembly’s Joint Budget Committee (JBC), provided the keynote address at the Colorado BioScience Association (CBSA) Annual All-Member Meeting yesterday at the University Club in Denver. In other action, 2008 association sponsors were announced, plus new and reappointed board members voted on by those in attendance. - April 30, 2008 - Colorado BioScience Association

AnaSpec Introduces a Suite of Phospho-Specific Anti-Her2 Antibodies

AnaSpec has introduced a full suite of phospho-specific ErbB-2 (Her-2) polyclonal antibodies. - April 30, 2008 - AnaSpec, EGT Group

Colorado BioScience Association Praises Governor Ritter’s Signing and Rep. Riesberg and Sen. Bacon’s Sponsorship of the Bioscience Research Grant Program (HB 1001)

Colorado Governor Bill Ritter has signed HB 1001, spurring development of the bioscience industry in Colorado. The Bioscience Research Grant Program puts $26.5 million over the next five years into several initiatives within Colorado’s bioscience industry. These funds and program will be managed by the Colorado Office of Economic Development and International Trade. - April 26, 2008 - Colorado BioScience Association

AnaSpec Introduces 13 New Antibody Products

AnaSpec added thirteen (13) new antibody products to its growing collection. - April 25, 2008 - AnaSpec, EGT Group

New Mike Hurst Article Available at Expert411.com Examines How to Prevent Infection from IV Therapy Complications, Including Nursing Perspective

Healthcare-associated infections are a staggering cause of increased provider costs and morbidity in the United States; and intravenous therapy complications are a major contributor to bloodstream infections. A new Mike Hurst-bylined article is now posted at the “Expert Information for Journalists” site about this topic. Hurst reviews the problem and gives perspective to what nurses surveyed know and believe about IV therapy complications. - April 24, 2008 - Baxa Corporation

SensoLyte™ MMP Assay Kits Offer a New Industry Standard for Sensitivity

AnaSpec’s SensoLyte™ line of MMP assay kits have quickly become the new standard in MMP assay sensitivity. - April 24, 2008 - AnaSpec, EGT Group

AnaSpec FRET-Based MMP Substrates Used in Double Differential in Vivo Zymography

AnaSpec FRET-based MMP substrates were recently used in a double differential in vivo zymography study at the University of New Brunswick. - April 23, 2008 - AnaSpec, EGT Group

Baxa Environmental Program Nets Significant Results

In celebration of Earth Day tomorrow, Baxa Corporation announces significant increase in environmental benefits through environmental stewardship and recycling programs. Baxa is committed to manufacturing operations that minimize the opportunity for environmental harm and support sustainable resources. - April 21, 2008 - Baxa Corporation

New Anti-MMP Antibodies Introduced by AnaSpec

AnaSpec has introduced its newest MMP antibodies. - April 11, 2008 - AnaSpec, EGT Group

Plymouth Pharmaceuticals and Dermatologist Cited in ‘Skin and Allergy News’ Regarding Drug’s (Acunol™) Role in Preventing Jewelry Allergy

The respected journal “Skin & Allergy News” recently released “Nickel Named Contact Allergen of the Year” in its current issue. Researcher Dr Katherine A Zug, of the Department of Dermatology at Dartmouth Hitchcock Medical Center in Lebanon, NH, has published her... - April 10, 2008 - Plymouth Pharmaceuticals Inc

"USP Chapter 797: Understanding the Revisions” Technical Paper by Baxa Corporation’s Mike Hurst Now Accessible on Expert411.com for Media and Professional Reference

The “USP Chapter 797: Understanding the Revisions” technical paper, authored by Baxa Corporation’s Mike Hurst, RPh, MBA, is now accessible at Expert411.com for media and professional reference. USP Chapter 797 became official on January 1, 2004. The first major revision was released on December 3, 2007, following years of soliciting feedback and the review of hundreds of responses by the USP Sterile Compounding Committee. June 1, 2008 is the effective date for the new standards. - March 31, 2008 - Baxa Corporation

AnaSpec Offers Fluo-3 - a High Affinity Fluorescent Calcium Indicator

Calcium plays a vital role in the specific and selective regulation of major cellular processes and is central in the regulation of cardiac contractility, growth and gene expression. Calcium indicators are small molecules that can respond to the binding of Ca2+ ions by changing their spectral... - March 29, 2008 - AnaSpec, EGT Group

Trevigen Launches LDEV Free Basement Membrane Extract

Trevigen launches LDVE Free Basement Membrane Extract within its Cultrex® product line of Cell Differentiation and Angiogenesis products. Basement Membrane Extract (BME) can be used for promotion and maintenance of a differentiated phenotype in a variety of cell cultures including primary... - March 29, 2008 - Trevigen, Inc.

Baxa Corporation Launches Call for Research Papers

Baxa to offer unrestricted educational grants for research studies on the usage and benefits of the new PadLock® Set Saver. Grants will be awarded for research intended for presentation at the INS, AVA, APIC or similar meetings and/or publication in the Journal of Infusion Nursing, Journal of Vascular Access, American Journal of Infection Control or similar publications. - March 28, 2008 - Baxa Corporation

Avanti Therapeutics Launches Chikujee Therapeutics, a Targeted Drug Delivery Company

Avanti Therapeutics, a privately held biopharmaceutical company, said it has incubated and launched a new bionanotechnology company for targeted drug delivery called Chikujee Therapeutics. Chikujee Therapeutics hopes to commercialize nanomedicines using its proprietary, cell specific targeted drug... - March 28, 2008 - Chikujee Therapeutics

AnaSpec Introduces Suite of Labeled & Unlabeled Anti-Actin Antibodies

AnaSpec has introduced a suite of labeled and unlabeled anti-Actin antibodies. - March 26, 2008 - AnaSpec, EGT Group

AnaSpec Introduces New Technical Support Solution

This month AnaSpec introduced a significantly improved online technical support resource for its website users. AnaSpec's new Frequently Asked Questions (FAQ) Page now offers a searchable database of solutions that offers a more convenient and more comprehensive solution for technical support needs. - March 22, 2008 - AnaSpec, EGT Group

Steriods on Barcode

Simple barcodes come of age. Immunoassays on barcodes seamlessly convey medical and drug abuse results, track patient progress and even alert patients of impending health problems. - March 20, 2008 - Prognosys LLC

AnaSpec Introduces Phosphopeptide Standards Kit

AnaSpec has introduced a dependable tool for the analysis and characterization of phosphorylated peptides – AnaSpec’s Phosphopeptide Standards Kit. - March 19, 2008 - AnaSpec, EGT Group

Biopharma Innovators Syntaxin Wins Top Honours at 2007 Interactive Media Awards

Biopharma firm Syntaxin's new website has won a very prestigious IMA award which recognises great design, technical innovation and accessibility compliance within the interactive media industry. - March 19, 2008 - Syntaxin Ltd

Baxa Corporation Announces Safe Handling and Preparation of Hazardous Drugs Course Offering at Its STAR Center Training Facility

Baxa Corporation announces a new course offered in its renowned STAR (Skills, Training, Academics and Resources) Center facility for nurses, physicians and pharmacists who prepare and handle hazardous drugs. The 10-hour course combines hands-on experience with regulatory compliance and industry best practice to provide the most complete training in hazardous drug compounding and safe handling available. - March 17, 2008 - Baxa Corporation

AnaSpec Introduces 58 New Antibody Products

Continuing to rapidly expand its antibody offerings, AnaSpec has added fifty-eight (58) new antibody products to its growing collection. Anti-PTEN (pSer385) (polyclonal) - Cat# 29642-025, 25 µg Host: rabbit polyclonal; Species Reactivity: human; rat; mouse; Applications: IP; WB;... - March 16, 2008 - AnaSpec, EGT Group

Now Available on CD: Baxa Corporation Exhibitor’s Theatre, The Pros and Cons of Standardized Parenteral Nutrition, from ASHP Midyear Clinical Meeting

Colorado-based pharmacy products manufacturer, Baxa Corporation now has a CD available of the presentation, 'The Pros and Cons of Standardized Parenteral Nutrition” recorded live at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas. Presenter Gordon S. Sacks, PharmD, FCCP, BCNSP discusses the research related to parenteral nutrition compounding and the recommendations for best practice. - March 10, 2008 - Baxa Corporation

Device Promises to Heal the World's Sleep Problems

Those seeking better sleep without drugs look to technology that guarantees deeper, more recuperative sleep and enhanced daytime productivity. - March 09, 2008 - EarthPulse Tech, LLC

AnaSpec Introduces New SensoLyte™ Cathepsin D Activity Assay Kits

AnaSpec has introduced a new series of SensoLyte™ Cathepsin D Activity Assay Kits to address the issue of autofluorescence interference. - March 09, 2008 - AnaSpec, EGT Group

Trevigen Launches Anti-8-oxo-dG Monoclonal Antibody (Clone 2E2)

DNA damage caused by oxidative radicals is associated with aging, inflammation, carcinogenesis, Parkinson’s and Alzheimer’s diseases. When exposed to oxidative radicals, 8-hydroxy-2’-deoxyguanosine (8-oxo-dG) is formed and can serve as a sensitive indicator of physiological and... - March 06, 2008 - Trevigen, Inc.

AnaSpec Introduces Two Novel Amino Acids

AnaSpec has introduced two novel amino acids that offer additional tools and functionality for peptide chemists. - March 05, 2008 - AnaSpec, EGT Group

Otava Ltd. and Institute of Genetics and Molecular Medicine at University of Edinburgh Announce Research Collaboration

Otava Ltd., a leading Ukrainian company that specializes in drug discovery technologies, and Institute of Genetics and Molecular Medicine at University of Edinburgh, Cancer Research UK-p53 Signal Transduction Laboratories (UK), have announced plans for an integrated research project focused on a... - March 02, 2008 - OTAVA Chemicals Ltd.

Colorado Biosciences Get Boost, Advancing Major Economic Development Program

The Colorado House gave a big boost to a critical economic development project on Tuesday. A bill expanding Colorado’s much lauded Bioscience Discoveries Grant Program passed the House by an initial voice vote. House Bill 1001, sponsored by State Representative Jim Riesberg (D-Greeley), will make $26.5 million available in grants over the next five years. HB 1001 will provide as much as $150,000 per project to Colorado research institutions, accelerating the development of new technologies. - February 28, 2008 - Colorado BioScience Association

AnaSpec Introduces 9 New Antibody Products

AnaSpec added nine new antibody products to its growing collection. - February 28, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 5 New Peptide Synthesis Reagents

AnaSpec added five (5) new peptide synthesis reagents to its combinatorial chemistry collection. - February 24, 2008 - AnaSpec, EGT Group

AnaSpec Introduces Collection of Channel Blocker Peptides

AnaSpec has introduced its selection of channel blocker peptides. - February 21, 2008 - AnaSpec, EGT Group

Trevigen Launches High-Throughput PARP/Apoptosis Assays

Trevigen launches High-Throughput PARP/Apoptosis Assays ideal for measuring the activity of PARP in 96-well plates. Cell extracts can be obtained using their newly-developed, higher-throughput procedure before, during and after apoptosis induction. During apoptosis, PARP-1 which catalyzes the NAD... - February 20, 2008 - Trevigen, Inc.

Clinical Trials in Russia, 4th Quarter 2007

On February 18, 2008 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. The report contains hundreds of figures as well as dozens of tables and pictures covering various aspects... - February 20, 2008 - Synergy Research Group

AnaSpec Introduces New Suite of Fluorescently Labeled GST & 6xHis Tag Antibodies

AnaSpec has introduced a suite of fluorescently labeled GST and 6X-His antibodies. These antibodies are labeled with a selection of dyes, including AnaSpec’s proprietary HiLyte FluorTM and HiLytePlusTM dyes, which span the visible spectrum. This gives researchers a wide range of wavelength... - February 16, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 46 New Antibody Products

Continuing to rapidly expand its antibody offerings, AnaSpec added forty-six (46) new antibody products to its growing collection. Anti - GST Tag AMCA labeled - Cat# 29531-AMCA, 100 µg Host: mouse monoclonal; Application: IHC Anti - GST Tag Biotin labeled - Cat# 29531-BIOT, 100... - February 13, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 21 New Anti-Tau Antibodies

AnaSpec has announced the release of 21 new anti-Tau antibodies. Complementing one of the world’s most comprehensive collections of beta-amyloid peptides, this new selection of anti-Tau antibodies demonstrates AnaSpec’s efforts to deliver new solutions for Alzheimer research. Tau is a... - February 11, 2008 - AnaSpec, EGT Group

Vascular BioSciences Awarded Phase 1 STTR Grant from the National Heart Lung Blood Institute of the National Institutes of Health for Pulmonary Hypertension Research

Vascular BioSciences announced today it has received a STTR Phase 1 grant from the National Heart Lung Blood Institute of the National Institutes of Health in the amount of $165,745. The STTR award, “Targeting Pulmonary Hypertension with R-Ras,” will be performed in collaboration with... - February 10, 2008 - Vascular BioSciences, Inc

Baxa Corporation Launches New Web Site

Baxa announces the launch of its new corporate Web site with enhanced user features and technical content. The site provides a global platform for information exchange, product marketing, public relations, and sales and technical support for health-system pharmacists and nurses, as well as pharmaceutical industry representatives. - January 31, 2008 - Baxa Corporation

Colorado BioScience Association and Six Economic Development Groups Tout Colorado’s Strengths to the Medical Device Industry at MD&M West in Anaheim

Representatives from the Colorado BioScience Association (CBSA) and six of the state’s economic development entities are marketing Colorado as a desirable medical device manufacturing hub at the 24th annual Medical Device & Manufacturing (MD&M) West Expo. - January 31, 2008 - Colorado BioScience Association

AnaSpec Introduces 9 New Antibody Products

Continuing to rapidly expand its antibody offerings, AnaSpec added nine (9) new antibody products to its growing collection. Anti-AKT pan (IN) - Cat# 54320, 50 µg Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; bovine; zebrafish; Applications: WB Anti-AKT pan (NT) - Cat#... - January 27, 2008 - AnaSpec, EGT Group

Xcelience Expands Its Early Drug Development Capabilities

The Tampa-based CRO is first to acquire next generation Xcelodose. - January 26, 2008 - Xcelience, LLC

Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock® Set Saver

New Baxa eCampaign targets IV Nurses to introduce the PadLock Set Saver and honors nurses for their dedication to patients. The PadLock Set Saver device is designed to promote best practice for aseptic IV administration set storage, preventing contamination of the administration set when disconnected from the patient. The Set Saver also eliminates the use of IV administration set caps, which are a known choking hazard – especially in pediatric applications. - January 25, 2008 - Baxa Corporation

Recent Headlines Within Biotechnology

Recent Headlines
Within Biotechnology